Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Firm Income Reported for This Client
$60K
Not substituted for client expenses
Summary
PROGENITOR CELL THERAPY is an organization, based in NJ. Its political footprint includes $60K in lobbying-firm income reported for this client. Lobbying activity focuses on Budget/Appropriations, Health Issues, Transportation, Science/Technology. Political activity spans from 2001 to 2003.